KLRK1 and cancer: They provide IFN‐γ‐associated type 1 responses against cancer and express critical determinants of tumor cell recognition, including their signature γδ TCR but also a variety of NK cell receptors (NKRs), among which the natural killer group 2 member D (NKG2D) is of utmost importance (Lança et al, 2010; Correia et al, 2013; Silva‐Santos et al, 2015; Wu et al, 2019).